Akeso, Inc. (9926.HK) (Akeso or the Company) announced that at the 2025 ESMO Asia Congress, updated results from the pivotal ...
IBI3003 is a novel trispecific antibody targeting GPRC5D, BCMA and CD3 simultaneously. Its dual-targeting design against BCMA and GPRC5 aims to overcome single antigen escape in multiple myeloma (MM).
In healthcare, the costs are not merely financial. Incomplete, inconsistent or delayed electronic health records can lead to ...
One thing about South Asian populations is that we do have a very different presentation of diabetes, partly due to our genetics, partly due to migration pressures”, says Rohini Mathur, Professor and ...
NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) (“NervGen” or the “Company”), a clinical-stage biopharmaceutical company ...
The latest announcement is out from Quality Power Electrical Equipments Ltd. ( (IN:QPOWER)). Quality Power Electrical Equipments Ltd. has released its earnings presentation for the second quarter and ...